Individual patient data meta-analysis of 13 RCTs (10 266 patients with localised prostate cancer on radiotherapy): longer ADT was associated with nonlinear gains in survival and metastasis, smaller beyond 9-12 months, and higher other-cause mortality (HR 1.28, 28 vs 0 months).
Meta-analysisn = 10,266
Zaorsky et al. Optimal Duration of Androgen Deprivation Therapy With Definitive Radiotherapy for Localized Prostate Cancer: A Meta-Analysis